Palliative and Supportive Care to Help People With Arthritis to Live Well (ENRICH)
ENRICH
Exploring Perspectives on Palliative and Supportive Care, to Inform Recommendations to Help People Live Well With Inflammatory Arthritis Throughout the Disease Course (ENRICH)
2 other identifiers
observational
120
1 country
1
Brief Summary
Palliative Care (PC) focuses on maximising quality of life and care for patients and their families in the last 1000 days of life. Supportive Care (SC) is provided earlier in life for people with a long-term health condition. People living with inflammatory arthritis, (such as rheumatoid arthritis) can experience ongoing pain, stiffness, limitations in their joints, and intrusive fatigue. This impacts daily living activities and emotional well-being. People with inflammatory arthritis would value support to manage symptoms across the course of their disease. They would like PC healthcare professionals (HCPs) to understand their conditions better, so they can live well to the end of their lives. Aims: The investigators will explore the potential role of Palliative and Supportive Care (PSC) for people with inflammatory arthritis. The investigators will describe any unmet patient need. The investigators will develop clinical and research recommendations to help people with inflammatory arthritis live well over the course of their disease. Plan: The investigators research will be conducted in three studies: Study 1: The investigators will conduct 1:1 online interviews with people with inflammatory arthritis to understand how PSC is perceived by them, and what their views are on how PSC may support them to live well. Study 2: The investigators will send an online survey to Rheumatologists, Primary Care, Community and PC HCPs, to understand:
- if and how they work together currently;
- their views on the role of PSC supporting people with inflammatory arthritis to live well. Study 3: The investigators will conduct online focus groups with volunteers from Studies 1 and 2, representatives from relevant national charities/organisations, and people who commission health services. Together the group will discuss the research findings and agree:
- what the gap in patient care is;
- recommendations for future clinical practice and research;
- the key areas of importance for patients which should be measured in future work
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2026
CompletedStudy Start
First participant enrolled
February 19, 2026
CompletedFirst Posted
Study publicly available on registry
March 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
March 25, 2026
January 1, 2026
11 months
January 20, 2026
March 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcomes
The primary outcomes for this research will be: * A description of the nature and scope of unmet patient need, * Clinical and research recommendations, informed by expert opinion and the 'six pillars' framework of the British Society of Lifestyle Medicine, which describe the potential role of PSC for people with inflammatory arthritis throughout the disease course. * Patient identified areas of importance which should be measured in future work.
through to study completion, an average of one year
Study Arms (1)
Inflammatory arthritis
Interventions
Eligibility Criteria
Adults with inflammatory arthritis
You may qualify if:
- Adults (\> 18 years) with a diagnosis of arthritis (Rheumatoid, Psoriatic or Juvenile Idiopathic) or Axial Spondyloarthritis
- able to understand and communicate in verbal and written English (or via an interpreter nominated by the participant or provided via an agency by the research team)
- in receipt, or not in receipt of Palliative Care services
- access to Microsoft Teams or a telephone
- consent to sharing preferred contact details
You may not qualify if:
- Cognitive impairment that impedes communication
- non-English speaker (should an interpreter not be available).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dorothy House Hospice
Bath, Wiltshire, BA15 2LE, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Dr Sharon Grieve Research Development and Delivery Lead, DPhil
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2026
First Posted
March 25, 2026
Study Start
February 19, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
March 25, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share